ESC Congress 2011

27 - 31 August 2011, Paris - France

Session Details

Poster session 2: Cardiomyopathies, other
Sun 28 Aug 14:00 - 18:00 Cardiomyopathies Poster Session Posters - Poster Zone C

Abstract Slides/e-posters Video Report

List of Presentations

Time
 
FP Nr
 
Title
 
Speakers
 
Related documents
14:00P1701Impact of the new 2010 task force criteria in the diagnosis of arrhythmogenic right ventricular dysplasia / cardiomayopathyJose Manuel RUBIO CAMPAL (Madrid, ES)
14:00P1702Clinical significance of giant negative T-waves in patients with tako-tsubo cardiomyopathy Birke SCHNEIDER (Luebeck, DE)
14:00P1703Prolonged mobilization of endothelial progenitor cells post Takotsubo cardiomyopathy. Thanh Ha NGUYEN (Adelaide, AU)
14:00P1704RNA interference targeting the matricellular protein CTGF (CCN2) modulate multiple interrelated pro-inflammatory and pro-fibrotic pathways in cardiofibroblastsJuliane TANK (Berlin, DE)
14:00P1705Diverse morphologic spectrum of stress-induced cardiomyopathy and its clinical presentationJihyun YOON (Seoul, KR)
14:00P1706Stress-induced cardiomyopathy (Tako-Tsubo syndrome) in Austria: a retrospective analysisValerie WEIHS (Vienna, AT)
14:00P1707Interleukin-1 receptor antagonist ameliorates radiation-induced cardiomyopathy in the mouseEleonora MEZZAROMA (Richmond, US)
14:00P1708Heart T2* for prediction of cardiac complications in well-treated thalassemia major patientsAntonella MELONI (Pisa, IT)
14:00P1709A new animal model of takotsubo cardiomyopathy by pilocarpine-induced epilepsy in rodentsTakahide ARAI (Tokyo, JP)
14:00P1710Cardiac involvement in systemic sclerosis: the added value of magnetic resonance imagingLuna GARGANI (Pisa, IT)
14:00P1711Takotsubo cardiomyopathy with critical coronary stenosis: clinical characteristics and comparison with typical takotsubo without coronary stenosisMario PREVITALI (Pavia, IT)
14:00P1712Altered cytoskeletal protein localization in cardiomyocytes of cardiomyopathy patients.To Be Announced
14:00P1713Clinical characteristics and outcome of patients with left ventricular aneurysms and diverticula presenting with arrhythmic manifestations: experience of a tertiary care centerLaurent M HAEGELI (Zollikon, CH)
14:00P1714Prospective assessment of incidence of Tako-Tsubo cardiomyopathyNicolas MANSENCAL (Boulogne-Billancourt, FR)
14:00P1715Beta2-adrenoceptor coupling to Gi protein: a key role in cardiac contractility impairment at early stage of doxorubicin-induced cardiomyopathyNolwenn MERLET (Nantes, FR)
14:00P1716Novel speckle tracking motion-based endocardial tracking algorith provides accurate left ventricular volumes: validation with quantitative cardiac magnetic resonance.Miguel SANTAULARIA (Baltimore, US)
14:00P1717Left ventricular hypertrabeculation in afro-caribbean individuals: an inherited cardiomyopathy or a physiological response to increased cardiac preloadSabiha GATI (London, GB)
14:00P1718Reduced thickness of compacted myocardial layer: a sensitive and specific echocardiographic criterion for left ventricular non-compactionCatherine GEBHARD (Zurich, CH)
14:00P1719Prospective study about relation between Tako-tsubo cardiomyopathy and major anxiety troubleClement DELMAS (Toulouse, FR)
14:00P1720Different patterns of myocardial iron overload by multislice T2* cardiovascular MR as markers of risk for cardiac dysfunction in thalassemia majorAntonella MELONI (Pisa, IT)
14:00P1721Different patterns of myocardial iron overload by T2* cardiovascular magnetic resonance as markers of risk for cardiac complication in thalassemia majorAntonella MELONI (Pisa, IT)
14:00P1722Three-dimensional echocardiographic characterization of patients with left ventricular non-compaction. Andrea SERDOZ (Rome, IT)
14:00P1723Angiographic evidence of coronary microvascular dysfunction in Tako-Tsubo syndromeLeda GALIUTO (Rome, IT)
14:00P1724Mechanical dyssynchrony in non-compaction cardiomyopathy: underlying mechanism for improved response to cardiac resynchronization therapy.Diego PENELA (Barcelona, ES)
14:00P1725Frequency of silent left ventricular systolic dysfunction in patients with malignant hemopathies treated with autologous peripheral blood stem cell transplantationXavier BOSCH (Barcelona, ES)
14:00P1726Myocardial interstitial remodelling in paucisymptomatic patients with initial dilated cardiomyopathyAndrea BARISON (Pisa, IT)
14:00P1727Spironolactone attenuates fibrosis via inhibiting TGF beta-1 Smad signaling in dilated cardiomyopathy To Be Announced
14:00P1728Comprehensive assessment of endomyocardial biopsy specimens in patiens with recent-onset dilated cardiomyopathy.Marek SRAMKO (Prague, CZ)
14:00P1729Early detection of epirubicin-induced cardiac dysfunction in patients with breast cancer by assessment of myocardial systolic rotation and deformationMaria FLORESCU (Bucharest, RO)
14:00P1730Value of serial measurements of troponin I and BNP to detect left ventricular systolic dysfunction in patients with malignant hemopathies treated with intensive chemotherapyXavier BOSCH (Barcelona, ES)
14:00P1731Diabetes mellitus is an independent determinant of impaired left ventricular diastolic reserve: a potential marker of subclinical diabetic cardiomyopathyMelissa LEUNG (Botany, AU)
14:00P1732Impaired myocardial perfusion is an independent predictor of chronic diastolic dysfunction in obstructive sleep apnoeaGirish DWIVEDI (Ottawa, CA)
14:00P1733Effects of granulocyte-colony stimulating factor on diabetic cardiomyopathy in sucrose fed otsuka long-evans tokushima fatty ratYoung-Hyo LIM (Seoul, KR)